Fig. 1From: Response to targeted therapy or chemotherapy following immunotherapy in patients with gastrointestinal cancers - a case seriesa Magnetic Resonance Imaging (MRI) scan in March 2018 after treatment with a PD-1 inhibitor. b MRI scan showing smaller lesions in May 2018 after treatment with SorafenibBack to article page
